Ingredients:News

Brazil updates its list of substances banned in cosmetics

On 7 January 2025, Brazil notified a draft Resolution designed to update the list of substances banned for use in personal hygiene products, cosmetics and perfumes. A 60-day consultation was opened.

SOPHIM: the choice of stability!

SOPHIM, a reliable supplier of olive squalane, for a secure & stable supply

Homosalate: new restrictions come into force

On this 1st january 2025, the new restrictions on the UV filter Homosalate set out in Regulation (EU) 2022/2195 come into force. They apply to all new products placed on the market.

United Kingdom: an omnibus regulation for 64 CMRs and Kojic Acid

On 17 December 2024, the UK published Statutory Instrument 2024 No.1334. It includes a ban on 64 CMR substances (eight of which have INCI names), and new restrictions on kojic acid.

US FDA proposes mandatory testing of talc-containing products

On 26 December 2024, the US FDA opened a consultation on a draft rule aimed at requiring talc-containing products to be tested for asbestos using standardised methods.

Tuesday, December 21, 2021

Perfumes & Cosmetics Congress: the Q&A of the competent authorities

Subscribers only

After their two respective interventions during the 19th Perfumes & Cosmetics Congress, which took place in Chartres on December 1st and 2nd, 2021...

Monday, December 20, 2021

SCCS: Preliminary Opinion on the revision of the Opinion on Vitamin A

Subscribers only

Following the mandate given by the European Commission to the SCCS in March 2021 in the context of the availability of new data on global exposure to ...

Monday, December 20, 2021

ECHA's Scientific committees support further restrictions of PFAS

Subscribers only

ECHA (European Chemicals Agency) announced that the Committees for Risk Assessment and Socio-Economic Analysis support Germany’s proposal to restrict ...

Monday, December 13, 2021

SCCS: Scientific advice on the safety of Homosalate

Subscribers only

Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disr...

Monday, December 13, 2021

BHT: the SCCS final Opinion

Subscribers only

Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disr...

Monday, December 13, 2021

New ECHA consultation on the proposed CLH classification of Hexyl Salicylate

Subscribers only

In February 2021, ECHA (European Chemicals Agency) had organised a consultation on the French proposal to classify Hexyl Salicylate (fragrance ingredi...

Wednesday, December 8, 2021

New allergen labelling: regulatory and practical aspects

Subscribers only

Since 2012 and a certain Opinion of the SCCS, the issue of labelling a considerably increased number of allergens has been worrying the cosmetics indu...

Wednesday, December 8, 2021

Intertek’s testing strategy for the determination of 57 allergens in cosmetics

Intertek, a leading Total Quality Assurance provider to industries worldwide, has launched advanced analytical tests to determine allergens in cosmeti...

Wednesday, December 8, 2021

New uses for Global Bioenergies' bio-sourced isododecane

Subscribers only

Global Bioenergies announces the success of new toxicological studies on its first cosmetic ingredient, naturally sourced isododecane, which can now b...

Thursday, December 2, 2021

HAA299 (nano): Final Opinion of the SCCS

Subscribers only

Following the mandate given by the European Commission to the SCCS in October 2020, the Scientific Committee has just published its final Opinion on t...

Thursday, December 2, 2021

Reminder: new labelling obligations for three hair dyes

Subscribers only

This 3 December 2021 marks the entry into force of the new labelling obligations under Regulation 2020/1683. They involve three hair dye ingredients, ...

Monday, November 15, 2021

Kojic Acid: the SCCS preliminary Opinion

Subscribers only

Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disr...